Table 1

Summary and pathway overview of candidate genes included in this review

PathwayGene symbol9Name9Cytogenetic location9Studies (n)
Lipid metabolismPNPLA3Patatin-like phospholipase domain-containing 322q13.3111
LPIN1Lipin 12p25.11
PPARAPeroxisome proliferator-activated receptor α22q13.312
PPARGPeroxisome proliferator-activated receptor γ3p25.25
PPARGC1APeroxisome proliferator-activated receptor γ, coactivator 1 α4p15.21
Lipoprotein transport and metabolismAPOC3Apolipoprotein C-III11q23.32
APOEApolipoprotein E19q13.324
OLR1 (LOX-1)Oxidised low-density lipoprotein receptor 112p13.21
PEMTPhosphatidylethanolamine N-methyltransferase17p11.22
MTTPMicrosomal triglyceride transfer protein4q235
Cholesterol biosynthesisSREBPF1Sterol regulatory element-binding transcription factor 117p11.21
SREBPF2Sterol regulatory element-binding transcription factor 222q13.21
Oxidative stressSOD2Superoxide dismutase 2, mitochondrial6q25.32
UCP3Uncoupling protein 311q13.41
GCLCGlutamate-cysteine ligase, catalytic subunit6p12.11
Inflammatory responseTNFTumour necrosis factor6p21.337
IFNL3 (IL28B)Interferon λ 319q13.21
IL6Interleukin 67p15.31
IL1Interleukin 12q131
CD14CD14 molecule5q31.31
TLR4Toll-like receptor 49q33.11
MIFMacrophage migration inhibitory factor (glycosylation-inhibiting factor)22q11.231
ADRB3Adrenoceptor β 38p11.231
Metabolic hormonesADIPOQAdiponectin, C1Q and collagen domain containing3q27.33
LEPRLeptin receptor1p31.32
Metabolism—transcription factorsSTAT3Signal transducer and activator of transcription 317q21.21
CLOCKClock circadian regulator4q121
MTHFRMethylenetetrahydrofolate reductase (NAD(P)H)1p36.222
KLF6Kruppel-like factor 610p15.11
CHUKconserved helix-loop-helix ubiquitous kinase10q24.311
Hepatic iron accumulationHFEHaemochromatosis6p22.26
TMPRSS6Transmembrane protease, serine 622q12.31
Profibrogenic factorsAGTAngiotensinogen1q42.21
AGTR1Angiotensin II receptor, type 13q242
TGFB1Transforming growth factor, β 119q13.21
SERPINE 1 (PAI-1)Serine peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 17q22.11
Glucose homoeostasisIRS1Insulin receptor substrate 12q36.31
ENPP1 (PC-1)Ectonucleotide pyrophosphatase/phosphodiesterase 16q23.2 2
GCKRGlucokinase regulator2p23.31
TCF7L2Transcription factor 7-like 210q25.2-q25.31
NeurologicalCNR1Cannabinoid receptor 16q151
CNR2Cannabinoid receptor 21p36.111
NCANNeurocan19p13.111
MiscellaneousTM6SF2Transmembrane 6, superfamily member 219p13.3-p123
SPINK1Serine peptidase inhibitor, Kazal type 15q321
ABCB11ATP-binding cassette, subfamily B (MDR/TAP), member 112q31.11
NR1H4Nuclear receptor subfamily 1, group H, member 412q23.11
CYP2E1Cytochrome P450, family 2, subfamily E, polypeptide 110q26.31
NR1I2Nuclear receptor subfamily 1, group I, member 23q12–q13.31
FABP2Fatty acid-binding protein 2, intestinal4q261
SLC27A5Fatty acid transport protein 519q13.43
CHDHCholine dehydrogenase3p21.11
SAMM50Sorting and assembly machinery component 22q13.311
GWASFDFT1Farnesyl diphosphate farnesyltransferase 18p23.11
EFCAB4BEF-hand calcium-binding domain 4B12p13.321
LTBP3Latent transforming growth factor β (TGF-β) binding protein11q13.11
SLC2A1Solute carrier family 2, member 11p34.21
COL13A1Collagen, type XIII, α 110q22.11
LYPLAL1Lysophospholipase-like 18q11.231
PPP1R3BProtein phosphatase 1, regulatory subunit 3B8p23.1 1
PARVBParvin, β22q13.311
GCKRGlucokinase regulator2p23.32
  • Highlighted genes indicate associations that have been replicated in more than one histologically characterised cohort.

  • GWAS, genome-wide association study.